Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical

a technology of the cerebrum and cognition, applied in the direction of biocide, muscular disorder, drug composition, etc., can solve the problems of inability to replace intact neurons, person might have stiff shoulders, and untrue, so as to achieve the maximum treatment effect, avoid undesired side effects, and suppress the exhaustion of physical strength of patients.

Inactive Publication Date: 2011-04-21
MINOWADA TAKURO
View PDF12 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0067]The present invention exerts such an effect that almost any diseases can be treated by a simple combination of two or more kinds of drugs which have previously been used.
[0068]According to the present invention, since a patient can receive therapy under a condition mild to the patient, the maximum treatment effect can be exerted while exhaustion of a physical strength of a patient is extremely suppressed, and an undesired side effect can be avoided.
[0069]The aforementioned object, other objects, characteristics and advantages of the present invention will become more apparent from the following detailed explanation of embodiments of the present invention with reference to the drawings.

Problems solved by technology

Meanwhile, there is a concern that if a person having such a heavy head at the top of the body has such a heavy thing placed on the head, this person might have stiff shoulders, but this is not true.
It is also reported that, even when a certain part gets damaged, intact neurons replace for it over a long time.
However, this seems trivial.
Japanese psychiatric medicine is directed to psychiatric analytical methodology too much, and is substantially delayed in study involving the function and the structure of cerebrum or positioning of those psychiatric medicines in the clinic setting.
We see objects or the surrounding situation through eyes every day, but we don't always actually “see” all things that meet eyes.
However, there is a fact that, in most cases, initial therapy, which is naturally conducted in other departments, is not conducted in the department of psychiatry.
With respect to “human genome plan” for which study and development have been rapidly progressed since 1990's, that is, a gene issue, in our country, only partial study of a DNA is marginally getting going, and control of its whole is substantially delayed.
However, change in medical education, overfocus on cultivation of physicians who can see only a part, and confusion between medicine and welfare greatly destruct the clinical field of medicine.
Further, it has been known that even when a cancer has entered a stage of proliferation / metastasis, intake of vitamin C may suppress the proliferation.
However, a family can provide a care but not treatment.
However, the Literature does not describe and suggest treatment of other diseases such as cancer utilizing the cognitive ability of a brain.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
  • Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
  • Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical

Examples

Experimental program
Comparison scheme
Effect test

example 1

Transverse Colon Cancer

[0154]In the present example, Mr. TM (76 year old) suffering from transverse colon cancer was treated as follows, and course of transverse colon cancer was observed. The body weight at treatment initiation was 62 kg.

[0155](Formulation)

[0156]A Celanese (haloperidol) 0.75 mg tablet was administered before bedtime at ½ tablet a day.

[0157]6.0 g of CPG (containing 1200 mg of ascorbic acid, and 18 mg of calcium pantothenate) was administered on an empty stomach.

[0158]At hospitalization, 500 ml of an Aldofed injection solution (maltose, potassium chloride, magnesium chloride, potassium hydrogen phosphate, potassium dihydrogen phosphate, sodium chloride, magnesium chloride (hexahydrate), anhydrous sodium acetate, maltose (monohydrate)) was infused at decreased appetite.

[0159]At reduction in blood potassium, SSR1 (Luvox (fluvoxamine maleate, 25 mg) two tablets) was administered.

[0160]At anemia, 1 to 2 tablets of Ferromia (sodium ferrous citrate) was administered on an ...

example 2

Treatment of Large Intestine Cancer Patient

[0173]Next, treatment of 11 large intestine cancer patients is described.

[0174](Treatment Method)

[0175]In principle, the same as Example 1.

[0176](Case and Results)

[0177]The following is course of treatment of the large intestine cancer patients.

TABLE 2DosingAnti-treatmentAliveBirthAge / Diseasecancerat thisorIDdateYearnametreatmenttimedeadHSJan. 21, 193669LargeLung21 yearsAliveintestinemetastasiscancer(OP)TMJun. 20, 192679LargeOP 5 AliveintestinecancerMKMar. 21, 194560Large4 years 4 yearsDeadintestineafter OP,cancerdosing wasstopped.Dead at 10months atYoga.HHMar. 31, 191986LargeOP 7 yearsDeadintestinecancerSNApr. 30, 191491Large 8 YearsDeadintestinecancerMNApr. 12, 191590Large 8 YearsDeadintestinecancerCHJun. 11, 193173LargeC only 6AliveintestineyearscancerTYDec. 11, 195252LargeOP11 YearsAliveintestineImpossiblecancertocompletelyexcise ( )KYSep. 22, 193965LargeOP II 6 YearsAliveintestineJapanesecancerRed CrossUterinecancerMKJun. 21, 191986Lar...

example 3

Treatment of Liver Cancer Patients

[0180]Next, treatment of 7 liver cancer patients is described.

[0181](Treatment Method)

[0182]In principle, the same as Example 1.

[0183](Case and Results)

[0184]The following is the course of treatment of the patients.

TABLE 3DosingAnti-treatmentAliveBirthAge / Diseasecancerat thisorIDdateYearnametreatmenttimedeadSKJan. 2, 193372Liver 8 yearsAlivecancerSKMar. 29, 193570Liver 4 monthsAlivecancerFSAug. 8, 194262LivercancerTFJan. 6, 193372LivercancerKMAug. 20, 192679Liver15 yearsAlivecancerHIJan. 28, 192580Liver12 yearsDeadcancerSHOct. 11, 191292Liver13 yearsDeadcancer

[0185](Findings)

[0186]In all cases, patients were still alive unexpectedly, or in dead cases, the life was remarkably prolonged as compared with the previously announced life.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
weightaaaaaaaaaa
weightaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

An object of the present invention is to develop a method of enhancing the cognitive ability of a brain to fundamentally cure a disease. It has been found out that, by using a medicament for treating or preventing a disease including a combination of a major tranquilizer, and vitamin C or a salt thereof and, if necessary, drip infusion, an antidepressant and an iron agent, the cognitive ability of a brain is enhanced, thus, an arbitrary disease including various cancers can be treated. The present invention also provides a method for treating or preventing a disease including a step of administering a major tranquilizer, and vitamin C or a salt thereof to a subject suffering from the disease.

Description

TECHNICAL FIELD[0001]The present invention relates to a method and a medicament for treating or preventing a disease. More particularly, the present invention relates to a method and a medicament for treating or preventing a disease using cognition of the cerebrum.BACKGROUND ARTStructure of Brain[0002]A structure of a brain is said to be most mysterious in this universe. A human brain is classified into cerebrum and cerebellum. Simply speaking, cerebrum is apart which controls the psychiatric function, and cerebellum is a part which controls balance sense. When these two are compared, the weight of cerebellum is around 11% of a whole brain, and cerebrum accounts for a major part. When a longitudinal cross-section of a brain is observed, in the center, there are diencephalon, mesencephalon, and medulla oblongata, and medulla oblongata which is continuous with spinal cord.[0003](Is a Brain Heavy?!)[0004]To say a weight of a whole brain, it is about 1450 gram in men, and is about 1300 ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/451A61P35/00
CPCA61K9/0019A61K9/0085A61K9/19A61K9/2018A61K45/06A61K31/375A61K31/4523A61K33/26A61K31/00A61K31/15A61K31/197A61K31/4515A61P21/00A61P21/04A61P25/14A61P35/00A61P35/02
Inventor MINOWADA, TAKURO
Owner MINOWADA TAKURO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com